Related Experiment Video
Updated: Jun 20, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine in children and adolescents
1Paediatric Neurosciences Unit, Royal Hospital for Children, Glasgow, UK.
Developmental Medicine and Child Neurology
|June 19, 2026
Summary
Migraine in children and adolescents involves complex genetics and varied symptoms, including related childhood migraine syndromes. Advances offer targeted treatments, but clinical assessment remains key due to a lack of biomarkers.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Migraine is a complex neurological disorder with a polygenic aetiology.
- Its presentation is influenced by intrinsic and extrinsic factors.
- Childhood migraine encompasses various related disorders.
Purpose of the Study:
- To review recent advances in migraine research.
- To focus on the aetiology, pathogenesis, and clinical presentation in children and adolescents.
- To explore potential new mechanism-based treatments.
Main Methods:
- Narrative review of current literature.
- Emphasis on genetic and pathophysiological studies.
- Analysis of clinical presentations and treatment strategies.
Main Results:
- Migraine pathophysiology involves multiple neurotransmitters.
- New targeted treatments for acute episodes and prevention are emerging.
- Clinical assessment is crucial for diagnosis in the absence of biomarkers.
Conclusions:
- Understanding migraine complexity reveals the need for personalized treatment approaches.
- No single medication will suit all patients.
- Further research into specific mechanisms is essential for effective management.
Related Concept Videos
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...